Search filters

List of works by Benjamin Y Kong

Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma

scientific article

Allosteric Effect of ATP on Na+,K+-ATPase Conformational Kinetics†

scientific article published in June 2007

Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma.

scientific article published on 19 January 2016

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.

scientific article published on 12 January 2016

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.

scientific article published on 16 May 2017

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

scientific article published on 28 April 2016

Identification of potential regulatory sites of the Na+,K+-ATPase by kinetic analysis

scientific article published in March 2004

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

scientific article published on 19 September 2016

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.

scientific article published on 21 March 2017

Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy.

scientific article

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.

scientific article published on 17 July 2017

Paulina is supported by:

About Paulina

Help